-
Loading metrics
Open Access
Peer-reviewed
Research Article
Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial
-
Jonas Sundén-Cullberg ,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Project administration, Writing – original draft
* E-mail: jonas.sunden-cullberg@ki.se
Affiliations Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
⨯ -
Puran Chen,
Roles Data curation
Affiliation Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
⨯ -
Henrike Häbel,
Roles Formal analysis, Writing – review & editing
Affiliation Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
⨯ -
Paul Skorup,
Roles Investigation
Affiliation Department of Medical Sciences, Section of Infectious Diseases, Uppsala University, Uppsala, Sweden
⨯ -
Helena Janols,
Roles Conceptualization
Affiliation Department of Medical Sciences, Section of Infectious Diseases, Uppsala University, Uppsala, Sweden
⨯ -
Johan Rasmuson,
Roles Investigation
Affiliation Infection and Immunology, Department of Clinical Microbiology, Umeå University, Umeå, Sweden
⨯ -
Katarina Niward,
Roles Investigation
Affiliation Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
⨯ -
Åse Östholm Balkhed,
Roles Investigation
Affiliation Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
⨯ -
Katerina Chatzidionysiou,
Roles Investigation
Affiliation Rheumatology Division, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
⨯ -
Hilmir Asgeirsson,
Roles Investigation
Affiliations Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
⨯ -
Ola Blennow,
Roles Investigation
Affiliations Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
⨯ -
Åsa Parke,
Roles Investigation
Affiliations Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
⨯ -
Anna-Karin Svensson,
Roles Investigation
Affiliations Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
⨯ -
Jagadeeswara Rao Muvva,
Roles Project administration
Affiliation Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
⨯ -
Hans-Gustav Ljunggren,
Roles Project administration, Resources
Affiliation Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
⨯ -
Karolinska KI/K COVID-19 Treatment Working Group ,
¶Membership of the Karolinska KI/K COVID-19 Treatment Working Group is listed in the Acknowledgments.
⨯ -
Anna-Carin Horne,
Roles Conceptualization, Writing – review & editing
Affiliation Theme of Children’s and Women’s Health, Karolinska University Hospital, Stockholm, Sweden
⨯ -
Ulrika Ådén,
Roles Conceptualization
Affiliation Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
⨯ -
Jan-Inge Henter,
Roles Conceptualization
Affiliation Childhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, Stockholm, Sweden
⨯ -
Anders Sönnerborg,
Roles Conceptualization
Affiliations Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
⨯ -
Jan Vesterbacka,
Roles Conceptualization, Investigation
Affiliations Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
⨯ -
Piotr Nowak,
Roles Conceptualization, Investigation
Affiliations Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden, Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden
⨯ - [ ... ],
-
Jon Lampa
Roles Conceptualization, Formal analysis, Funding acquisition, Project administration, Writing – review & editing
Affiliation Rheumatology Division, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
⨯ - [ view all ]
- [ view less ]
Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial
- Jonas Sundén-Cullberg,
- Puran Chen,
- Henrike Häbel,
- Paul Skorup,
- Helena Janols,
- Johan Rasmuson,
- Katarina Niward,
- Åse Östholm Balkhed,
- Katerina Chatzidionysiou,
- Hilmir Asgeirsson
- Published: December 29, 2023
- https://doi.org/10.1371/journal.pone.0295838